Press Releases

AUSTIN, Texas, Jan. 12, 2020 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced 2019 highlights and 2020 guidance.All amounts in this release are in conformity with U.S. generally accepted accounting principles ("GAAP").  Preliminary results, contained herein, are based on management's initial analysis of operations for the qu

SAN FRANCISCO, Jan. 12, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, announced preliminary unaudited full-year 2019 results, driving strong g

DALLAS, Jan. 11, 2020 /PRNewswire/ -- Bayer AG (OTCMKTS: BAYZF) and its Monsanto subsidiary are hoping to minimize losses at the expense of nearly 43,000 cancer victims who have filed suit after falling ill following exposure to the popular weed killer Roundup. According to estimates, Bayer and Monsanto could face claims that double or triple the number of lawsuits curre

NEW ORLEANS, Jan. 10, 2020 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 28,  2020 to file lead plaintiff applications in a securities class action lawsuit

WASHINGTON, Jan. 10, 2020 /PRNewswire/ -- The American Pharmacists Association (APhA) applauds the U.S Supreme Court's decision to hear Rutledge v. Pharmaceutical Care Management Association, which addresses the State of Arkansas' regulation of pharmacy benefit managers (PBM). The Arkansas law is inte

PHOENIX, Jan. 10, 2020 /PRNewswire/ -- Paradigm Diagnostics, Inc. announced that Palmetto GBA, the Medicare Administrative Contractor (MAC) for the Molecular Diagnostics MolDX program, has reviewed the technical dossier and broadly approved the Paradigm Cancer Diagnostic (PCDx) assay under the Local Coverage Determination for next-generation sequencing for solid tum

VANCOUVER, Jan. 10, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications targeting diseases with high unmet medical needs, today confirmed that at its annual general meeting of shareholders held on December 19, 2019

SAN DIEGO, Jan. 10, 2020 /PRNewswire/ -- Companion Medical, Inc., an innovative diabetes company that developed the first and only FDA-cleared smart insulin pen and app system,

NAPERVILLE, Ill., Jan. 10, 2020 /PRNewswire/ -- To further advance its mission and dedication to delivering a world-class patient experience, Edward-Elmhurst Health, a three-hospital system serving the west and southwest suburbs of Chicago, has selected SwipeSense as its technology partner to prevent hospital-acquired infections, eff

BERWYN, Pa., Jan. 10, 2020 /PRNewswire/ -- RM LAW, P.C. announces an investigation on behalf of Surgery Partners, Inc. ("Surgery Partners" or the "Company") (NASDAQ: SGRY) investo